ARCHIVES

FDA Ceases Exclusion Of Women From Early Drug Studies

This article is from The Cancer Letter archive.

Vol. 19 No. 19 | May 7, 1993

Download PDF Visit The Full Archive

Related Articles

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

Cancer Centers Program To Implement Most Changes Sought By review Group

December 13, 1996

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

Erin Fox: Shortages to Continue for 4-6 Years

October 11, 2013

Two Groups Take Different Approaches To Managing Toxicity Of Saltz Regimen.

June 22, 2001

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

July 2, 2004